Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Latest filing published 18 Sept 2024 for Silk Road Medical Inc.
Filing timeline
BuySaleRichard Ruedy
Insider track record
Disclosed buys
0
Disclosed sells
13
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Richard Ruedy: trading record in brief
Richard Ruedy (chief executive) discloses dealings in Silk Road Medical Inc to SEC (Form 4). In total, 38 filings cover trades dated from 8 May 2019 to 17 September 2024.
Sales make up the whole of the open-market record (13 sales, €4.8M). Besides market trades, the filings include 11 share grants and 11 option exercises. 2024 to date brings no purchases and 2 sales.
The newest entry dates from 18 September 2024: a transaction, in Silk Road Medical Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Richard Ruedy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
205,711 sharesCommon StockSEC:0001140361-24-041416:0
3,800 shares@ US$17.1697.4% of flowCommon StockSEC:0001593968-24-000435:0
3,000 shares@ US$22.257.6% of flowCommon StockSEC:0001593968-24-000412:0
28,354 shares0Common StockSEC:0001593968-23-001324:0
13,341 shares0Common StockSEC:0001593968-23-000430:0
17,950 shares0Common StockSEC:0001593968-22-000650:0
7,407 shares@ US$55.0074.0% of flowCommon StockSEC:0001593968-21-002041:0
7 of 7 declarations
